Development of pouchitis with combination therapy with peg-interferon alpha-2b and ribavirin for chronic hepatitis C in a patient with ulcerative colitis who underwent pouch surgery

Am J Gastroenterol. 2009 Jun;104(6):1609-10. doi: 10.1038/ajg.2009.120. Epub 2009 Apr 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Colitis, Ulcerative / complications
  • Colitis, Ulcerative / surgery*
  • Endoscopy, Gastrointestinal
  • Female
  • Follow-Up Studies
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Ileostomy / methods*
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Polyethylene Glycols
  • Pouchitis / chemically induced*
  • Pouchitis / diagnosis
  • Recombinant Proteins
  • Ribavirin / adverse effects*
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b